ESCALON MEDICAL CORP (ESMC): auditor change — Escalon Medical dismisses Friedman LLP, engages Marcum LLP as auditor; going concern noted

ESCALON MEDICAL CORP

Board dismissed Friedman and engaged Marcum effective Oct 28, 2022, following Friedman's combination with Marcum.
No disagreements or reportable events occurred during the past two fiscal years or interim period through Oct 28, 2022.
Friedman's FY2021 and FY2022 reports included going concern qualification due to accumulated deficit, recurring losses, negative cash flows.
Friedman provided a letter concurring with the disclosures, filed as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ESCALON MEDICAL CORP dismissed Friedman LLP as its auditor.

Action: dismissal
Auditor: Friedman LLP
Successor: Marcum LLP

Exact text from the filing

On October 28, 2022, the Registrant’s Board of Directors (i) dismissed Friedman and (ii) engaged Marcum to serve as the independent registered public accounting firm of the Registrant and to provide to the Registrant the services previously provided to the Registrant by Friedman.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ESCALON MEDICAL CORP engaged Marcum LLP as its auditor.

Action: engagement
Auditor: Marcum LLP

Exact text from the filing

On October 28, 2022, the Registrant’s Board of Directors (i) dismissed Friedman and (ii) engaged Marcum to serve as the independent registered public accounting firm of the Registrant and to provide to the Registrant the services previously provided to the Registrant by Friedman.

View on SEC.gov

Browse all auditor changes →

ESCALON MEDICAL CORP filing history →

Source: SEC EDGAR

accession 0001213900-22-068665

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.